Competing interests
CKL reports stock by Theraklion and Phaon Scientific (self and family), honoraria by Roche, AstraZeneca, Celgene, Novartis, Pfizer, Lilly, Hexal, Amgen, SonoScape (self) and Genomic Health, Amgen, AstraZeneca, Riemser, Carl Zeiss MediTec, TEVA Pharmaceuticals Industries, Theraklion, Janssen-Cilag, GlaxoSmithKline, LIV Pharma (family), Consulting to Roche, Novartis, Pfizer, Celgene, Phaon Scientific (self) and Pfizer, Novartis, SurgVision, CarlZeissMeditec, Amgen, Onkowissen (family); research funding by Roche, Novartis, Pfizer (self) as well as Travel and Accomodation by Roche, Daiichi Sankyo, Novartis (self) and Carl Zeiss Meditec, LIV Pharma, Novartis, Amgen, Pfizer, Daiichi Sankyo (family). FF reports research funding by IOMX Therapeutics AG (Research Collaboration). MG none. MC none. RK reports honoraria by Amgen, Celgene, Genomic Health, NanoString Technologies, Novartis pharma, Pfizer Pharmaceuticals and Roche (family); consulting/advisory role by Agendia, AstraZeneca, Celgene, Daiichi Sankyo, Lilly, Merck Sharp & Dohme, Novartis pharma, Odonate Therapeutics, Pfizer Pharmaceuticals, Roche/Genentech, Sandoz (family); Research funding by the West German Study Group (self) and Genentech, Novartis, Boehringer Ingelheim and Pfizer (self). EG none. HF none. MB reports honoraria by AstraZeneca, Exact Sciences, Novartis, Pfizer, Roche, Teva; Consulting/Advisory Role by AstraZeneca, Exact Sciences, Novartis, Puma, Roche and Travel/Accomodation by AstraZeneca, Celgene, Medac, Novartis, Roche. MW none. JH none. CU reports Consulting/Advisory Role by Tesaro, Novartis, Roche, Research Funding by West German Study Group, German Breast Group, Novartis, AstraZeneca, Tesaro, Palleos Healthcare Services Gmbh, Pierre Fabre, AGO-Studiengrouppe; Travel/Accomodation by German Breast Group, West German Study Group, AGO-Studiengruppe; Speakers’ Bureau by Pfizer, Novartis, Roche, PharmaMar, AstraZeneca. BA reports Consulting/Advisory Role by Pfizer, Roche Pharma, Merck Sharp & Dohme, onkowissen.de, Novartis Pharma, AstraZeneca, PharmaMar, Lilly, promedicis; Travel /Accomodation by astraZeneca, Roche, Novartis, Pfizer. CS none. SK reports Consulting/Advisory Role by Roche, Genomic Health, Novartis, AstraZeneca, Amgen, Celgene, SOMATEX Medical Technologies, Daiichi Sankyo, PFM medical, Pfizer, MSD, Puma Biotechnology; Travel/accommodation by Roche, Daiichi Sankyo; other relationship as Co-Director West German Study Group. RW report Served as advisor, consultant, speaker and travel grants by Agendia, Amgen, Aristo, Astra Zeneca, Boeringer Ingelheim, Carl Zeiss, Celgene, Clinsol, Daiichi Sankyo, Eisai, Exact Sciences, Genomic Health, Gilead, Glaxo Smith Kline, Hexal, Lilly, Medstrom Medical, MSD, Mundipharma, Nanostring, Novartis, Odonate, Paxman, Palleos, Pfizer, Pierre Fabre, PumaBiotechnolgogy, Riemser, Roche, Sandoz/Hexal, Seattle Genetics /Seagen, Tesaro Bio, Teva, Veracyte, Viatris. MG none. UN reports honoraria by Agendia, Amgen, Celgene, Genomic Health, NanoString Technologies, Novartis pharma, Pfizer Pharmaceuticals, Roche/Genentech, Teva; Consulting/Advisory Role by Genomic Health, Roche; Research Funding by Agendia, Amgen, Celgene, Genomic Health, NanoString Technologies, Roche, Sanofi; Expert Testimony by Genomic Health; Travel/Accommodation by Genomic Health, Pfizer Pharmaceuticals, Roche; other relationship as Co-Director West German Study Group. HK none. OG reports honoraria by Genomic Health/Exact Sciences, Roche, Celgene, Pfizer, Novartis, NanoString Technologies, AstraZeneca; Consulting/Advisory Rola by Celgene, Genomic Health/Exact Sciences, Lilly, MSD, Novartis, Pfizer, Roche; Travel/Accomodation by Roche; other relationship as Co-Director West German Study Group. NH reports honoraria by Amgen, AstraZeneca, Genomic Health, Novartis, Pfizer, Pierre Fabre, Roche, Zodiac Pharma; Consulting/Advisory Role by Agendia, AstraZeneca, Celgene, Daiichi Sankyo, Lilly, Merck Sharp & Dohme, Novartis, Odonate Therapeutics, Pfizer, Pierre Fabre, Roche/Genentech, Sandoz, Seattle Genetics, West German Study Group (family); Research Funding by Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche/Genentech; other relationship as Co-Director West German Study Group.